Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

1 of 0 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A

1(50.0%)

Phase 2

1(50.0%)

2Total

N/A(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT07430501Not Yet Recruiting

Using Digital Twin Technology and Clinical Decision Support Systems to Improve the Early Detection, Personalised Treatment, and Long-term Monitoring of Patients Across the Full Spectrum of Metabolic-associated Fatty Liver Disease (MAFLD).

Role: collaborator

NCT07163689Recruiting

TIPS for Complicated Portal Hypertension Related to Porto-Sinusoidal Vascular Disease

Role: collaborator

NCT05510817Not ApplicableRecruiting

Multiparametric Assessment to Investigate Prognostic Factors for Disease Evolution a nd Evolutionary Patterns of Cognitive Status in RRMS

Role: collaborator

NCT01266018Phase 2Terminated

Study of ADI-PEG 20 in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer

Role: collaborator

All 4 trials loaded